Recruiting
Ketamine Treatment Plans for Chronic Conditions
A study aimed to assess the efficacy of the various approaches to prescribing Ketamine currently in use off-label. The focus will be to include ketamine within the study plan of those with chronic conditions who are receiving ketamine.
ClinicalTrials.gov IDNCT06038409
PhaseNot Applicable
Enrollment500
SponsorRIVER Foundation
Age18 Years
SexALL
Conditions studied
Chronic Pain, Depressive Disorder, Anxiety Disorders, Chronic Disease
About this study
A study aimed to assess the efficacy of the various approaches to prescribing Ketamine currently in use off-label. The focus will be to include ketamine within the study plan of those with chronic conditions who are receiving ketamine.
Interventions
- Drug: Ketamine — The efficacy of the various approaches to prescribing Ketamine currently in use off-label. The focus will be to include ketamine within the treatment plan of those with chronic conditions
Primary outcomes
- Ketamine route of use acceptability. (through study completion, an average of 1 year)
- Mental Health PHQ9 (through study completion, an average of 1 year)
- Mental Health GAD7 (through study completion, an average of 1 year)
- Mental Health PCL5 (through study completion, an average of 1 year)
Eligibility information
Inclusion Criteria:
Must have an identifiable chronic condition.
Exclusion Criteria:
Healthy population
Study locations
- RIVER Telehealth, Helena, Montana 59601 United States
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.